ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 681750 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 681750; 2) Community: the network communities that were significantly associated with the response to NSC 681750; 3) Molecule: the relationships between components within communities and NSC 681750; 4) MDR: the compounds that were significantly associated with the NSC 681750.

NSC Compound Enrichment Correlation
NSC 134727 MITOMYCIN C 0.0366216145653011 -0.095195891
NSC 187546 Ethanimidamide, 2-chloro-N-(tricyclo[3.3.1.1(3,7)]dec-1-ylmethyl)-, monohydrochloride 0.0366216145653011 -0.3253141
NSC 275971 Null 0.0366216145653011 -0.32200915
NSC 315626 Butyric acid, rhodium salt (4:2) 0.0366216145653011 -0.3441602
NSC 326408 Rocaglamide (FR AGLAIA ELLIPTIFOLIA) 0.0366216145653011 -0.39614293
NSC 34927 Null 0.0366216145653011 -0.16482104
NSC 606699 Rapamycin prodrug, Mono-(28)-N,N-diethylpropionate-, hydrochloride salt 0.0366216145653011 0.30396469
NSC 619837 Null 0.0366216145653011 -0.29745847
NSC 643248 23,27-Epoxy-3H-pyrido[2,1-c] [1,4]oxaazacyclohentriacontine-1,5,11,28,29-pentone-, 1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31, 32,33,34,34a-tetracosahydro- 27-hydroxy-10,21-dimethoxy-3-[2 0.0366216145653011 0.36554428
NSC 646395 Null 0.0366216145653011 -0.24362042
Total:55  Current:40    [First] [Prev] [Next] [Last]